Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tyrosine-ester sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.82e-09	4	147	4	GO:0017067
GeneOntologyMolecularFunction	amine sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.82e-09	4	147	4	GO:0047685
GeneOntologyMolecularFunction	flavonol 3-sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.40e-08	5	147	4	GO:0047894
GeneOntologyMolecularFunction	steroid sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.70e-08	7	147	4	GO:0050294
GeneOntologyMolecularFunction	sulfate binding	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.45e-07	9	147	4	GO:0043199
GeneOntologyMolecularFunction	aryl sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.72e-07	10	147	4	GO:0004062
GeneOntologyMolecularFunction	3'-phosphoadenosine 5'-phosphosulfate binding	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.91e-06	13	147	4	GO:0050656
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCF1 DHX40 ABCC5 RNF213 SMARCAD1 DDX6 ABCG4 DDX18 KIF28P ATP1A2 DYNC1H1	4.32e-04	441	147	11	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	ABCF1 DHX40 ACTC1 ABCC5 RNF213 SMARCAD1 DDX6 MYO5C ABCG4 DDX18 KIF28P ATP1A2 DYNC1H1	6.24e-04	614	147	13	GO:0140657
GeneOntologyMolecularFunction	sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.18e-04	55	147	4	GO:0008146
GeneOntologyBiologicalProcess	mesenchyme migration	ACTA1 ACTA2 ACTC1 ACTG2	1.01e-08	5	140	4	GO:0090131
GeneOntologyBiologicalProcess	4-nitrophenol metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.01e-08	5	140	4	GO:0018960
GeneOntologyBiologicalProcess	3'-phosphoadenosine 5'-phosphosulfate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.52e-06	17	140	4	GO:0050427
GeneOntologyBiologicalProcess	purine ribonucleoside bisphosphate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.52e-06	17	140	4	GO:0034035
GeneOntologyBiologicalProcess	ethanol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.52e-06	17	140	4	GO:0006068
GeneOntologyBiologicalProcess	ethanol metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.78e-06	18	140	4	GO:0006067
GeneOntologyBiologicalProcess	primary alcohol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.63e-05	23	140	4	GO:0034310
GeneOntologyBiologicalProcess	sulfation	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.16e-05	27	140	4	GO:0051923
GeneOntologyBiologicalProcess	xenobiotic metabolic process	CYP26A1 ABCC5 SULT1A2 SULT1A4 SULT1A1 SULT1A3 RORA	5.06e-05	141	140	7	GO:0006805
GeneOntologyBiologicalProcess	flavonoid metabolic process	SULT1A4 SULT1A1 SULT1A3	8.33e-05	13	140	3	GO:0009812
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	PDE4B CYP26A1 ABCC5 SULT1A2 SULT1A4 SULT1A1 SULT1A3 RORA	1.40e-04	222	140	8	GO:0071466
GeneOntologyBiologicalProcess	protein autoubiquitination	ITCH UBE4B WWP2 LRSAM1 RNF213	1.90e-04	78	140	5	GO:0051865
GeneOntologyBiologicalProcess	cyclic purine nucleotide metabolic process	PDE4B PDE8A GUCY2C RORA	2.24e-04	44	140	4	GO:0052652
GeneOntologyBiologicalProcess	cerebellar Purkinje cell differentiation	CACNA1A TTC21B RORA	2.32e-04	18	140	3	GO:0021702
GeneOntologyBiologicalProcess	cyclic nucleotide metabolic process	PDE4B PDE8A GUCY2C RORA	2.44e-04	45	140	4	GO:0009187
GeneOntologyBiologicalProcess	pro-T cell differentiation	FLT3 ZBTB1	2.72e-04	4	140	2	GO:0002572
GeneOntologyBiologicalProcess	alcohol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.89e-04	47	140	4	GO:0046164
GeneOntologyBiologicalProcess	cerebellar Purkinje cell layer formation	CACNA1A TTC21B RORA	3.21e-04	20	140	3	GO:0021694
GeneOntologyCellularComponent	filopodium	UBE2K ACTA1 ACTA2 ACTC1 ACTG2 ITGAV UTRN DYNC1H1	2.44e-06	123	146	8	GO:0030175
GeneOntologyCellularComponent	actin-based cell projection	UBE2K ACTA1 ACTA2 ESPNL ACTC1 ACTG2 ITGAV CDC14A UTRN DYNC1H1	2.66e-05	278	146	10	GO:0098858
GeneOntologyCellularComponent	cell body	CACNA1A CACNA1B ACTA1 ACTA2 ACTC1 ACTG2 GRIK4 RRM1 WDR47 TMEM132E SIPA1L1 ATP1A2 NRSN1 CNGA3 ALK TOP1 DYNC1H1	2.71e-04	929	146	17	GO:0044297
MousePheno	enlarged gallbladder	ITCH SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.75e-06	28	121	5	MP:0009342
MousePheno	abnormal gallbladder size	ITCH SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.47e-06	32	121	5	MP:0020134
Domain	Actin_CS	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	1.07e-07	16	145	5	IPR004001
Domain	ACTINS_2	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	1.51e-07	17	145	5	PS00432
Domain	Actin/actin-like_CS	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	2.08e-07	18	145	5	IPR020902
Domain	ACTINS_1	ACTA1 ACTA2 ACTC1 ACTG2	2.38e-07	8	145	4	PS00406
Domain	ACTINS_ACT_LIKE	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	2.80e-07	19	145	5	PS01132
Domain	Actin	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	3.80e-06	31	145	5	IPR004000
Domain	Actin	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	3.80e-06	31	145	5	PF00022
Domain	ACTIN	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	3.80e-06	31	145	5	SM00268
Domain	-	GIMAP4 ABCF1 SAMD9 DHX40 ABCC5 RNF213 SMARCAD1 DDX6 RABL6 ABCG4 SULT1A2 TRANK1 RHOBTB1 SULT1A1 N4BP2 DDX18 GPN3 DYNC1H1 NLRP13	5.25e-06	746	145	19	3.40.50.300
Domain	P-loop_NTPase	GIMAP4 ABCF1 SAMD9 DHX40 ABCC5 RNF213 SMARCAD1 DDX6 MYO5C RABL6 ABCG4 SULT1A2 TRANK1 RHOBTB1 SULT1A1 N4BP2 DDX18 GPN3 DYNC1H1 NLRP13	9.09e-06	848	145	20	IPR027417
Domain	E3_ub_ligase_SMURF1	WWP1 WWP2	5.99e-05	2	145	2	IPR024928
Domain	Sulfotransfer_1	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.69e-04	36	145	4	PF00685
Domain	Sulfotransferase_dom	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.69e-04	36	145	4	IPR000863
Domain	WW	ITCH WWP1 WWP2 UTRN	4.80e-04	47	145	4	PF00397
Domain	WW	ITCH WWP1 WWP2 UTRN	5.20e-04	48	145	4	SM00456
Domain	WW_DOMAIN_1	ITCH WWP1 WWP2 UTRN	6.56e-04	51	145	4	PS01159
Domain	WW_DOMAIN_2	ITCH WWP1 WWP2 UTRN	6.56e-04	51	145	4	PS50020
Domain	WW_dom	ITCH WWP1 WWP2 UTRN	7.07e-04	52	145	4	IPR001202
Domain	HECT	ITCH WWP1 WWP2	1.17e-03	27	145	3	PF00632
Domain	HECTc	ITCH WWP1 WWP2	1.17e-03	27	145	3	SM00119
Domain	HECT_dom	ITCH WWP1 WWP2	1.17e-03	27	145	3	IPR000569
Domain	HECT	ITCH WWP1 WWP2	1.17e-03	27	145	3	PS50237
Domain	HISTONE_H3_1	H3-4 H3C1	1.23e-03	7	145	2	PS00322
Domain	Ca_chan_IQ	CACNA1A CACNA1B	1.23e-03	7	145	2	SM01062
Domain	Ca_chan_IQ	CACNA1A CACNA1B	1.23e-03	7	145	2	PF08763
Domain	VDCC_a1su_IQ	CACNA1A CACNA1B	1.23e-03	7	145	2	IPR014873
Domain	GPHH	CACNA1A CACNA1B	1.23e-03	7	145	2	PF16905
Domain	GPHH_dom	CACNA1A CACNA1B	1.23e-03	7	145	2	IPR031649
Domain	HISTONE_H3_2	H3-4 H3C1	1.63e-03	8	145	2	PS00959
Domain	Histone_H3/CENP-A	H3-4 H3C1	1.63e-03	8	145	2	IPR000164
Domain	H3	H3-4 H3C1	1.63e-03	8	145	2	SM00428
Domain	CUE	SMARCAD1 N4BP2	2.59e-03	10	145	2	IPR003892
Domain	CUE	SMARCAD1 N4BP2	2.59e-03	10	145	2	PS51140
Domain	VDCCAlpha1	CACNA1A CACNA1B	2.59e-03	10	145	2	IPR002077
Domain	ANF_lig-bd_rcpt	GRIK4 GRIN2D GUCY2C	2.94e-03	37	145	3	IPR001828
Domain	ANF_receptor	GRIK4 GRIN2D GUCY2C	2.94e-03	37	145	3	PF01094
Domain	Pkinase_Tyr	FLT3 TYK2 GUCY2C ALK EPHA1	3.35e-03	129	145	5	PF07714
Domain	Peripla_BP_I	GRIK4 GRIN2D GUCY2C	3.41e-03	39	145	3	IPR028082
Domain	PTPase_domain	CDC14A PTP4A2 PTPN3	3.94e-03	41	145	3	IPR000242
Domain	Y_phosphatase	CDC14A PTP4A2 PTPN3	3.94e-03	41	145	3	PF00102
Domain	ABC_transporter_CS	ABCF1 ABCC5 ABCG4	4.22e-03	42	145	3	IPR017871
Domain	Ser-Thr/Tyr_kinase_cat_dom	FLT3 TYK2 GUCY2C ALK EPHA1	4.47e-03	138	145	5	IPR001245
Domain	Tyr_kinase_cat_dom	FLT3 TYK2 ALK EPHA1	4.91e-03	88	145	4	IPR020635
Domain	TyrKc	FLT3 TYK2 ALK EPHA1	4.91e-03	88	145	4	SM00219
Domain	-	MRPL39 SDHB	5.12e-03	14	145	2	3.10.20.30
Domain	Beta-grasp_dom	MRPL39 SDHB	5.12e-03	14	145	2	IPR012675
Domain	AAA	ABCF1 ABCC5 RNF213 ABCG4 DYNC1H1	5.34e-03	144	145	5	SM00382
Domain	AAA+_ATPase	ABCF1 ABCC5 RNF213 ABCG4 DYNC1H1	5.34e-03	144	145	5	IPR003593
Domain	ABC_tran	ABCF1 ABCC5 ABCG4	6.14e-03	48	145	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCF1 ABCC5 ABCG4	6.14e-03	48	145	3	PS50893
Domain	ABC_TRANSPORTER_1	ABCF1 ABCC5 ABCG4	6.50e-03	49	145	3	PS00211
Domain	cNMP-bd_CS	PRKAR2A CNGA3	6.69e-03	16	145	2	IPR018488
Domain	ABC_transporter-like	ABCF1 ABCC5 ABCG4	6.88e-03	50	145	3	IPR003439
Domain	PROTEIN_KINASE_TYR	FLT3 TYK2 ALK EPHA1	6.91e-03	97	145	4	PS00109
Domain	Tyr_kinase_AS	FLT3 TYK2 ALK EPHA1	6.91e-03	97	145	4	IPR008266
Pathway	KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.16e-08	5	116	4	M47807
Pathway	KEGG_SULFUR_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.94e-06	13	116	4	M18256
Pathway	REACTOME_PARACETAMOL_ADME	ABCC5 SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.59e-05	39	116	5	MM15695
Pathway	WP_ESTROGEN_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.84e-05	22	116	4	MM15888
Pathway	WP_RETINOL_METABOLISM	CYP26A1 SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.91e-05	44	116	5	MM15851
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.42e-05	23	116	4	MM14597
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.07e-05	24	116	4	M16289
Pathway	REACTOME_PARACETAMOL_ADME	ABCC5 SULT1A4 SULT1A1 SULT1A3	8.82e-05	29	116	4	M45015
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ABCF1 ITCH WWP2 SLC6A15 BCKDHA SMARCAD1 CNPY2 RRM1 LGALS3BP MRPL17 LRIG2 MRPL39 LMAN1 H3C1 ERAP2 GLG1 N4BP2 DDX18 NUP133 MTR PRKAR2A TMEM131L DLAT DAAM1 SNRPE SDHB WDR62	1.71e-10	1487	148	27	33957083
Pubmed	Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.15e-10	4	148	4	24318996
Pubmed	Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.15e-10	4	148	4	33414449
Pubmed	Steroid sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.15e-10	4	148	4	8943792
Pubmed	A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.15e-10	4	148	4	12390022
Pubmed	Molecular cloning of cDNA encoding the phenol/aryl form of sulfotransferase (mSTp1) from mouse liver.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.15e-10	4	148	4	8424956
Pubmed	Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.15e-10	4	148	4	8288252
Pubmed	Bioactivation of food genotoxicants 5-hydroxymethylfurfural and furfuryl alcohol by sulfotransferases from human, mouse and rat: a comparative study.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.15e-10	4	148	4	25370010
Pubmed	HIV-1 Nef impairs heterotrimeric G-protein signaling by targeting Gα(i2) for degradation through ubiquitination.	ITCH ACTA1 ACTA2 ACTC1 ACTG2	1.01e-09	12	148	5	23071112
Pubmed	Identification of a new subfamily of sulphotransferases: cloning and characterization of canine SULT1D1.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.57e-09	5	148	4	11389699
Pubmed	Hemoglobin adducts of furfuryl alcohol in genetically modified mouse models: Role of endogenous sulfotransferases 1a1 and 1d1 and transgenic human sulfotransferases 1A1/1A2.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.57e-09	5	148	4	29908303
Pubmed	The effect of knockout of sulfotransferases 1a1 and 1d1 and of transgenic human sulfotransferases 1A1/1A2 on the formation of DNA adducts from furfuryl alcohol in mouse models.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.57e-09	5	148	4	25053625
Pubmed	Determination of sulfotransferase forms involved in the metabolic activation of the genotoxicant 1-hydroxymethylpyrene using bacterially expressed enzymes and genetically modified mouse models.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.57e-09	5	148	4	24802129
Pubmed	Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	9971772
Pubmed	Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	10074138
Pubmed	Virus assembly and plasma membrane domains: which came first?	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	22989508
Pubmed	HIV-1 protease cleaves actin during acute infection of human T-lymphocytes.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	1540415
Pubmed	HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	11709093
Pubmed	Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	10049817
Pubmed	Human immunodeficiency virus nucleocapsid protein polymorphisms modulate the infectivity of RNA packaging mutants.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	12009869
Pubmed	HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	23811015
Pubmed	Retroviral assembly and budding occur through an actin-driven mechanism.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	19883584
Pubmed	Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	21917091
Pubmed	HIV-1 Gag protein associates with F-actin present in microfilaments.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	8661406
Pubmed	A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	23017337
Pubmed	Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	23875777
Pubmed	Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.	ACTA1 ACTA2 ACTC1 ACTG2	4.69e-09	6	148	4	9841925
Pubmed	The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry.	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-08	7	148	4	22535526
Pubmed	Chromosomal localization of three vacuolar-H+ -ATPase 16 kDa subunit (ATP6V0C) genes in the murine genome.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.09e-08	7	148	4	12438748
Pubmed	Selective targeting of ITK blocks multiple steps of HIV replication.	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-08	7	148	4	18443296
Pubmed	The trinity of the cortical actin in the initiation of HIV-1 infection.	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-08	7	148	4	22640593
Pubmed	HIV-1 replication from after cell entry to the nuclear periphery.	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-08	7	148	4	17504171
Pubmed	siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-08	7	148	4	22465675
Pubmed	The mouse Plk gene: structural characterization, chromosomal localization and identification of a processed Plk pseudogene.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.09e-08	7	148	4	9370299
Pubmed	Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.17e-08	8	148	4	10594240
Pubmed	Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production.	ACTA1 ACTA2 ACTC1 ACTG2	2.17e-08	8	148	4	14694110
Pubmed	Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.	ACTA1 ACTA2 ACTC1 ACTG2	2.17e-08	8	148	4	20147394
Pubmed	Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.	ACTA1 ACTA2 ACTC1 ACTG2	2.17e-08	8	148	4	23260110
Pubmed	Msx3: a novel murine homologue of the Drosophila msh homeobox gene restricted to the dorsal embryonic central nervous system.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.90e-08	9	148	4	8887328
Pubmed	Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.90e-08	9	148	4	23207770
Pubmed	Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.90e-08	9	148	4	19548878
Pubmed	Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.	ACTA1 ACTA2 ACTC1 ACTG2	3.90e-08	9	148	4	10556093
Pubmed	Structure of the human gene (COX6A2) for the heart/muscle isoform of cytochrome c oxidase subunit VIa and its chromosomal location in humans, mice, and cattle.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.90e-08	9	148	4	9177785
Pubmed	The gene encoding the heart/muscle isoform of cytochrome c oxidase subunit VIII maps to mouse chromosome 7.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.90e-08	9	148	4	9166597
Pubmed	Molecular characterization and mapping of murine genes encoding three members of the stefin family of cysteine proteinase inhibitors.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.90e-08	9	148	4	8468045
Pubmed	Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.90e-08	9	148	4	9060415
Pubmed	Cytoskeletal proteins inside human immunodeficiency virus type 1 virions.	ACTA1 ACTA2 ACTC1 ACTG2	3.90e-08	9	148	4	8892894
Pubmed	HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.	ACTA1 ACTA2 ACTC1 ACTG2	3.90e-08	9	148	4	18775311
Pubmed	Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.	ACTA1 ACTA2 ACTC1 ACTG2	6.48e-08	10	148	4	1907279
Pubmed	Non-viral cellular substrates for human immunodeficiency virus type 1 protease.	ACTA1 ACTA2 ACTC1 ACTG2	6.48e-08	10	148	4	1991513
Pubmed	Gelsolin activity controls efficient early HIV-1 infection.	ACTA1 ACTA2 ACTC1 ACTG2	6.48e-08	10	148	4	23575248
Pubmed	Rat phenol-preferring sulfotransferase genes (Stp and Stp2): localization to mouse chromosomes 7 and 17.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.48e-08	10	148	4	7601475
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ABCF1 ITCH WASHC4 UBE4B DHX40 LRSAM1 WDR70 SMARCAD1 RRM1 DDX6 WDR47 DDX18 MCM3AP EIF2B3 NUP133 DLAT PRKDC UTRN SNRPE TOP1 DYNC1H1 SEC23A	7.16e-08	1353	148	22	29467282
Pubmed	Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases.	ITCH WWP1 WWP2	7.55e-08	3	148	3	12450395
Pubmed	Identification of two human brain aryl sulfotransferase cDNAs.	SULT1A4 SULT1A1 SULT1A3	7.55e-08	3	148	3	8363592
Pubmed	A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.	SULT1A4 SULT1A1 SULT1A3	7.55e-08	3	148	3	9855620
Pubmed	Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16.	SULT1A2 SULT1A1 SULT1A3	7.55e-08	3	148	3	8912648
Pubmed	Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization.	ACTA1 ACTA2 ACTC1	7.55e-08	3	148	3	7780165
Pubmed	CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.	ACTA1 ACTA2 ACTC1 ACTG2	1.02e-07	11	148	4	30962377
Pubmed	N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton.	ACTA1 ACTA2 ACTC1 ACTG2	1.02e-07	11	148	4	23294842
Pubmed	Localization of the murine cholecystokinin A and B receptor genes.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.02e-07	11	148	4	7613026
Pubmed	Sulfotransferases in the bioactivation of xenobiotics.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.02e-07	11	148	4	11154739
Pubmed	Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.02e-07	11	148	4	8954725
Pubmed	Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.02e-07	11	148	4	9034160
Pubmed	Sulfotransferases: genetics and role in toxicology.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.02e-07	11	148	4	10720750
Pubmed	Quantitative proteomic analysis of lentiviral vectors using 2-DE.	ACTA1 ACTA2 ACTC1 ACTG2	1.02e-07	11	148	4	19639585
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ABCF1 ITCH WASHC4 TTC28 UBE4B LRSAM1 ABCC5 SMARCAD1 REV3L INTS8 DSCAML1 WDR47 SIPA1L1 DDX18 NABP2 DLAT PRKDC ATP1A2 UTRN TOP1 DYNC1H1	1.35e-07	1285	148	21	35914814
Pubmed	Identification of four chromosomal loci determining obesity in a multifactorial mouse model.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.52e-07	12	148	4	7706460
Pubmed	SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice.	ACTA1 ACTA2 ACTC1 CCND2	1.52e-07	12	148	4	31042497
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	ITCH CILP KRT84 CTSC WWP1 WWP2 ACTA1 ACTA2 ACTC1 ACTG2 ITGAV LGALS3BP MYO5C FREM2 PPP2R1B GLG1 PRKAR2A POTEJ DYNC1H1	1.60e-07	1070	148	19	23533145
Pubmed	PHR1 encodes an abundant, pleckstrin homology domain-containing integral membrane protein in the photoreceptor outer segments.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.18e-07	13	148	4	10585447
Pubmed	Structural and chemical profiling of the human cytosolic sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.18e-07	13	148	4	17425406
Pubmed	Disinhibition of the HECT E3 ubiquitin ligase WWP2 by polymerized Dishevelled.	ITCH WWP1 WWP2	3.01e-07	4	148	3	26701932
Pubmed	Interaction of the Brain-Selective Sulfotransferase SULT4A1 with Other Cytosolic Sulfotransferases: Effects on Protein Expression and Function.	SULT1A4 SULT1A1 SULT1A3	3.01e-07	4	148	3	32152050
Pubmed	LIM kinase 1 - dependent cofilin 1 pathway and actin dynamics mediate nuclear retinoid receptor function in T lymphocytes.	ACTA1 ACTA2 ACTC1 ACTG2	3.05e-07	14	148	4	21923909
Pubmed	Regulating the functions of the HIV-1 matrix protein.	ACTA1 ACTA2 ACTC1 ACTG2	3.05e-07	14	148	4	17411366
Pubmed	cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.14e-07	15	148	4	1741163
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	ABCF1 TBKBP1 ACTA1 ACTA2 ACTC1 ACTG2 RNF213 H3-4 LGALS3BP DDX6 H3C1 PRKDC UTRN TOP1 DYNC1H1 SEC23A	6.98e-07	844	148	16	25963833
Pubmed	Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1.	ACTA1 ACTA2 ACTC1 ACTG2	7.18e-07	17	148	4	17360745
Pubmed	The cleavage of host cell proteins by HIV-1 protease.	ACTA1 ACTA2 ACTC1 ACTG2	7.18e-07	17	148	4	8997639
Pubmed	A Tunable Brake for HECT Ubiquitin Ligases.	ITCH WWP1 WWP2	7.50e-07	5	148	3	28475870
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	CACNA1A GIMAP4 SZT2 ABCC5 RNF213 CNPY2 DDX6 FREM2 TRANK1 SULT1A1 GUCY2C EIF2B3 UTRN	7.65e-07	552	148	13	10737800
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	RNF213 BCKDHA PRKDC UTRN DYNC1H1 SEC23A	9.17e-07	76	148	6	27542412
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.20e-07	18	148	4	20056724
Pubmed	Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis.	ACTA1 ACTA2 ACTC1 PRKAR2A	1.16e-06	19	148	4	18316483
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ITCH TTC28 PLCXD1 WWP1 RNF213 BCKDHA SMARCAD1 REV3L EZH1 LGALS3BP TYK2 SIPA1L1 DDX18 MCM3AP MTR DLAT TOP1 WDR62	1.38e-06	1116	148	18	31753913
Pubmed	Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins.	ITCH WWP1 WWP2	1.50e-06	6	148	3	9647693
Pubmed	Retinoic acid regulates differentiation of the secondary heart field and TGFbeta-mediated outflow tract septation.	CYP26A1 ACTA1 ACTA2 ACTC1	1.78e-06	21	148	4	20230754
Pubmed	Myocardial Mycn is essential for mouse ventricular wall morphogenesis.	ACTA1 ACTA2 ACTC1 CCND2	1.78e-06	21	148	4	23063798
Pubmed	Inactivation of Wt1 causes pre-granulosa cell to steroidogenic cell transformation and defect of ovary development†.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.78e-06	21	148	4	32301970
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	VPS33A ACTA1 ACTA2 ACTC1 ACTG2 BCKDHA RRM1 H3-4 LGALS3BP DDX6 PPP2R1B H3C1 NUP133 MTR PRKAR2A PRKDC DYNC1H1 SEC23A SDHB	1.79e-06	1257	148	19	37317656
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	ABCF1 TBKBP1 DHX40 ACTA1 DDX6 MRPL39 DDX18 PRKAR2A DLAT PRKDC SNRPE NLRC3 TOP1 DYNC1H1 WDR62	2.08e-06	809	148	15	32129710
Pubmed	Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression.	ACTA1 ACTA2 ACTC1 ACTG2	2.17e-06	22	148	4	16526095
Pubmed	Cytosolic GDH1 degradation restricts protein synthesis to sustain tumor cell survival following amino acid deprivation.	UBE2K RNF213 H3C1	2.61e-06	7	148	3	34269483
Pubmed	Transmembrane adaptor protein WBP1L regulates CXCR4 signalling and murine haematopoiesis.	ITCH WWP1 WWP2	2.61e-06	7	148	3	31845480
Pubmed	Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.	ACTA1 ACTA2 ACTC1	2.61e-06	7	148	3	9384381
Pubmed	A Novel Mouse Model for Cilia-Associated Cardiovascular Anomalies with a High Penetrance of Total Anomalous Pulmonary Venous Return.	ACTA1 ACTA2 ACTC1	2.61e-06	7	148	3	30289203
Pubmed	Essential and supporting host cell factors for HIV-1 budding.	ACTA1 ACTA2 ACTC1 ACTG2	2.62e-06	23	148	4	22004035
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	ABCF1 ITCH ACTC1 SLC6A15 BCKDHA LGALS3BP DDX6 DDX18 MTR PRKDC SNRPE TOP1 DYNC1H1 SEC23A	2.91e-06	725	148	14	27025967
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	ACTA1 ACTA2 ACTC1 ACTG2 ABCC5 SLC6A15 BCKDHA RRM1 H3-4 LMAN1 H3C1 GLG1 NABP2 NUP133 DLAT SEC23A	3.30e-06	952	148	16	38569033
Interaction	SULT1A3 interactions	FLT3 SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.33e-07	24	147	5	int:SULT1A3
Interaction	SULT1C2 interactions	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.67e-06	19	147	4	int:SULT1C2
Interaction	TRIM66 interactions	ITCH WWP1 RNF213 LGALS3BP TYK2 SIPA1L1 MCM3AP MTR WDR62	2.01e-05	205	147	9	int:TRIM66
Interaction	ATOH1 interactions	RNF213 BCKDHA PRKDC UTRN DYNC1H1 SEC23A	2.62e-05	80	147	6	int:ATOH1
Interaction	ACTG2 interactions	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	2.84e-05	49	147	5	int:ACTG2
Interaction	PDE10A interactions	PDE8A PRKAR2A CNGA3 TOP1	3.59e-05	26	147	4	int:PDE10A
Interaction	POTEJ interactions	ACTA1 ACTA2 ACTC1 ACTG2 POTEJ	3.80e-05	52	147	5	int:POTEJ
Interaction	PFN3 interactions	ACTA2 ACTC1 POTEJ	4.39e-05	10	147	3	int:PFN3
Cytoband	Ensembl 112 genes in cytogenetic band chr11q23	GRIK4 DSCAML1 DDX6 ABCG4 PPP2R1B DLAT	8.46e-05	220	148	6	chr11q23
GeneFamily	Actins	ACTA1 ACTA2 ACTC1 ACTG2	1.72e-08	6	107	4	929
GeneFamily	Sulfotransferases, cytosolic	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.11e-06	14	107	4	762
GeneFamily	C2 and WW domain containing	WWP1 WWP2	2.07e-04	4	107	2	838
Coexpression	DARWICHE_PAPILLOMA_RISK_HIGH_DN	TCTE1 TSSK6 BEST1 UBE4B FAM178B ACTA1 ACTA2 WDR70 ACTG2 LHX3	1.06e-07	185	148	10	M1137
Coexpression	DARWICHE_PAPILLOMA_RISK_HIGH_DN	TCTE1 TSSK6 BEST1 UBE4B FAM178B ACTA1 ACTA2 WDR70 ACTG2 LHX3	2.29e-07	201	148	10	MM500
Coexpression	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	TCTE1 TSSK6 UBE4B FAM178B ACTA1 ACTA2 WDR70 ACTG2 LHX3	1.18e-06	186	148	9	M1140
Coexpression	BROWNE_HCMV_INFECTION_20HR_DN	PDE4B REV3L MAP3K5 RHOBTB1 SIPA1L1 RABGAP1L FILIP1L	1.87e-06	102	148	7	M5601
Coexpression	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	TCTE1 TSSK6 UBE4B FAM178B ACTA1 ACTA2 WDR70 ACTG2 LHX3	2.24e-06	201	148	9	MM502
Coexpression	DARWICHE_PAPILLOMA_RISK_LOW_DN	TSSK6 BEST1 UBE4B FAM178B ACTA1 ACTA2 ACTG2 NRSN1	6.31e-06	172	148	8	M1134
Coexpression	VERNOCHET_ADIPOGENESIS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.50e-06	24	148	4	MM1317
Coexpression	DARWICHE_PAPILLOMA_RISK_LOW_DN	TSSK6 BEST1 UBE4B FAM178B ACTA1 ACTA2 ACTG2 NRSN1	1.12e-05	186	148	8	MM498
Coexpression	LANDIS_ERBB2_BREAST_TUMORS_324_DN	PDE8A ACTA2 SULT1A2 SULT1A4 SULT1A1 SULT1A3 SEC23A	3.19e-05	157	148	7	MM1099
Coexpression	GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP	ACTA1 ITGAV ANKRA2 RABGAP1L TTC21B RORA SNRPE	3.60e-05	160	148	7	M339
Coexpression	ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP	SAMD9 WWP1 RRM1 ITGAV ZBTB1 LMAN1 ERAP2 N4BP2 RABGAP1L DDX18 MTR RORA SNRPE SEC23A	3.68e-05	687	148	14	M41022
Coexpression	ONKEN_UVEAL_MELANOMA_UP	UBE2K TTC28 CTSC WWP1 REV3L INTS8 CCND2 SULT1A2 SULT1A1 SULT1A3 RABGAP1L MCM3AP MTR PRKDC ALK	4.32e-05	790	148	15	M12490
Coexpression	LE_EGR2_TARGETS_DN	SLC6A15 SULT1A2 SULT1A4 SULT1A1 SULT1A3 UTRN	5.47e-05	117	148	6	MM1139
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	UBR2 FLT3 WASHC4 UBE4B ACTA2 WDR70 EZH1 ITGAV DDX6 MAP3K5 CCND2 WDR47 ERAP2 RABGAP1L MTR GTF2H5 PRKDC DAAM1 DYNC1H1	5.69e-05	1215	148	19	M41122
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	PDE8A TTC28 RNF213 ITGAV RHOBTB1 SIPA1L1 RORA	6.59e-05	176	148	7	M39223
Coexpression	LANDIS_BREAST_CANCER_PROGRESSION_DN	PDE8A SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.74e-05	75	148	5	MM1084
Coexpression	TABULA_MURIS_SENIS_MAMMARY_GLAND_ENDOTHELIAL_CELL_AGEING	GIMAP4 TTC28 CNPY2 CCND2 SULT1A2 SULT1A4 LMAN1 SULT1A1 SULT1A3 GTF2H5 CHURC1 SDHB	7.88e-05	556	148	12	MM3787
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	UBE2K WASHC4 SPPL2B CDC14A SULT1A2 SULT1A4 SULT1A1 SULT1A3 RABGAP1L MTR	9.44e-05	399	148	10	M41172
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	GIMAP4 UBR2 PDE4B SAMD9 RNF213 REV3L ZBTB1 CDC14A DDX6 CCND2 PTP4A2 TRANK1 ERAP2 GLG1 RABGAP1L MTR TMEM131L RORA UTRN NLRC3 DYNC1H1	1.01e-04	1492	148	21	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	UBR2 ITCH WASHC4 PDE8A TTC28 WWP1 REV3L SIPA1L1 RABGAP1L NUP133 MTR TMEM131L DAAM1 TOP1 FILIP1L	1.06e-04	856	148	15	M4500
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	MRPL17 SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.16e-04	84	148	5	MM873
Coexpression	DARWICHE_SKIN_TUMOR_PROMOTER_DN	TCTE1 TSSK6 BEST1 UBE4B FAM178B ACTA1 WDR70	1.21e-04	194	148	7	M1132
Coexpression	GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS	REV3L PTP4A2 RORA TOP1 FILIP1L	1.22e-04	85	148	5	M43623
Coexpression	GSE45837_WT_VS_GFI1_KO_PDC_UP	WDR70 SPPL2B RABL6 LMAN1 RORA UTRN CNGA3	1.25e-04	195	148	7	M9892
Coexpression	GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	ITCH PDE8A BCKDHA CNPY2 SLC7A7 MAP3K5 EIF2B3	1.33e-04	197	148	7	M3196
Coexpression	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	UBR2 UBE2K WWP1 MAP3K5 CTH ALK TOP1 EPHA1	1.37e-04	265	148	8	M19170
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP	PDE4B H3-4 LGALS3BP MYO5C DDX18 ACOXL EPHA1	1.37e-04	198	148	7	M5584
Coexpression	GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP	PUS3 SMARCAD1 MRPL39 TMEM131L CTH TOP1 FILIP1L	1.42e-04	199	148	7	M5604
Coexpression	GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN	GIMAP4 ACTG2 SLC7A7 H3-4 ITGAV CCND2 DDX18	1.46e-04	200	148	7	M7271
Coexpression	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN	UBE2K ITCH WASHC4 DHX40 ACTA1 HIF3A GTF2H5	1.46e-04	200	148	7	M5005
Coexpression	GSE360_CTRL_VS_L_MAJOR_MAC_UP	UBE4B ACTA2 EZH1 GLG1 NUP133 GTF2H5 SNRPE	1.46e-04	200	148	7	M5160
Coexpression	KANG_DOXORUBICIN_RESISTANCE_DN	WASHC4 WWP1 PTP4A2	1.60e-04	19	148	3	M3323
Coexpression	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	UBE4B WWP1 CCND2 PTPN3 PRKAR2A	1.78e-04	92	148	5	M11682
Coexpression	TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING	CYP26A1 SULT1A2 SULT1A4 SULT1A1 SULT1A3 CTH	1.92e-04	147	148	6	MM3753
Coexpression	SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP	SAMD9 H3-4 LGALS3BP MAP3K5 PTP4A2 H3C1 RABGAP1L CTH SNRPE	1.99e-04	356	148	9	M41052
Coexpression	SWEET_LUNG_CANCER_KRAS_DN	GIMAP4 ACTA1 ACTA2 ACTC1 SULT1A2 SULT1A4 SULT1A1 SULT1A3 ACKR2 ATP1A2	2.24e-04	444	148	10	MM1051
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP	GIMAP4 UBE2K WASHC4 CTSC SLC7A7 SULT1A4 SULT1A3 RABGAP1L EIF2B3 GTF2H5 CHURC1 GPN3	2.33e-04	625	148	12	M41067
Coexpression	INGRAM_SHH_TARGETS_UP	SULT1A2 SULT1A4 SULT1A1 SULT1A3 RORA FILIP1L	2.65e-04	156	148	6	MM550
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FAM178B ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 PPIP5K1 ATP1A2 FILIP1L	2.14e-08	197	148	9	470e23dee4ca35e1fd021b7cdd58fcbc90639837
ToppCell	PBMC-Severe-cDC_9\|Severe / Compartment, Disease Groups and Clusters	GIMAP4 SAMD9 CTSC RNF213 LGALS3BP SULT1A1 RABGAP1L CHURC1 TOP1	2.43e-08	200	148	9	ea3b22126d9dfd158bb3c3e1323b30514d721ded
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 ANKRD36C CDC14A LRIG2 SULT1A3 RORA UTRN ALK	2.80e-07	193	148	8	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACTA2 ACTG2 HIF3A SULT1A3 NABP2 LMOD1 ATP1A2	8.95e-07	155	148	7	cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	1.86e-06	173	148	7	ecbf7167d4bec685e3460d826318544946f5f5c2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	1.86e-06	173	148	7	b8dc978c52de64afba21ff6cb32e79f07167448e
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM178B ACTA2 ACTG2 LMOD1 IGSF1 ATP1A2 FILIP1L	2.52e-06	181	148	7	fc51468c74534b60b4e786bd512d0f1c5dc05de7
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SAMD9 RNF213 IFNB1 TRANK1 ERAP2 RABGAP1L UTRN	2.71e-06	183	148	7	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CILP ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.01e-06	186	148	7	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RNF213 ANKRD36C CDC14A TMEM131L RORA UTRN DYNC1H1	3.23e-06	188	148	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	GIMAP4 SAMD9 RNF213 LGALS3BP TRANK1 ERAP2 TOP1	3.23e-06	188	148	7	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CILP ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.35e-06	189	148	7	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PDE8A MAP3K5 RHOBTB1 GLG1 ETNK2 MTR RORA	3.35e-06	189	148	7	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GIMAP4 CCND2 PTP4A2 GLG1 RORA UTRN FILIP1L	3.47e-06	190	148	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CILP ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.47e-06	190	148	7	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.59e-06	191	148	7	d35692c652977500a3c36aa26c347a072b71e441
ToppCell	Mild/Remission-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CACNA1A SAMD9 RNF213 LGALS3BP TRANK1 RABGAP1L UTRN	3.59e-06	191	148	7	382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA1 ACTA2 ACTG2 XIRP2 LMOD1 ATP1A2 FILIP1L	3.59e-06	191	148	7	f932980baa032748857cb367a55c37dd975c693e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.59e-06	191	148	7	2a107e9096eb58b81b3da61547904d85754f6b2f
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TTC28 WDR70 HIF3A ANKRA2 MTR DAAM1 UTRN	3.72e-06	192	148	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.85e-06	193	148	7	5182284dfa7c94027e94172e08f78c86b95d63f4
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.85e-06	193	148	7	5260ac95a15cc43a19909badad0c7e3854da920d
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.85e-06	193	148	7	5ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CACNA1A GIMAP4 SAMD9 CTSC RNF213 LGALS3BP RABGAP1L	3.85e-06	193	148	7	22455801194bd8c73c5c397f5eac4f723429c383
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.85e-06	193	148	7	4f7bab0115469c855160636d168bd6e5d4e2dd2f
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CACNA1A SAMD9 RNF213 LGALS3BP TRANK1 RABGAP1L UTRN	3.98e-06	194	148	7	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PDE4B ACTA2 ACTG2 GRIK4 LMOD1 RORA FILIP1L	3.98e-06	194	148	7	3c661c6768c3f05d2aba03d329adb257ca201b2d
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GIMAP4 SMARCAD1 KDM5D CDC14A CCND2 MTR UTRN	4.12e-06	195	148	7	4b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	GIMAP4 WWP1 ANKRD36C CDC14A CCND2 TRANK1 RORA	4.12e-06	195	148	7	22191d361af136942508f1553ff41a626ed982ad
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW12-Neuronal-GABAergic_neurons\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ACTA1 GRIK4 GRIN2D FREM2 LMOD1 RORA ALK	4.12e-06	195	148	7	efdea22118d5be46c5abfe8e3fbe39503390665d
ToppCell	Pericytes\|World / shred by cell class for parenchyma	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	4.26e-06	196	148	7	8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e
ToppCell	(5)_Fibroblast-K_(Pericytes)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	4.26e-06	196	148	7	e3c89c5bd674289738d5590ebfd30c605f5156a5
ToppCell	Mild-CD4+_T_activated\|Mild / Disease group and Cell class	GIMAP4 PDE4B SAMD9 WASHC4 LGALS3BP TRANK1 ERAP2	4.26e-06	196	148	7	daa1c3322d81e649161e889e1d78451d2d425d09
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GIMAP4 PDE4B SAMD9 CCND2 TRANK1 ERAP2 RORA	4.40e-06	197	148	7	0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GIMAP4 PDE4B SAMD9 CCND2 TRANK1 ERAP2 RORA	4.40e-06	197	148	7	b3876076684781fb8384117f2cf367d828985986
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACTA2 ACTC1 SLC6A15 LMOD1 CTH ATP1A2 FILIP1L	4.55e-06	198	148	7	f261a37dd07976548b897af86df1d1a0dc069889
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GIMAP4 SAMD9 CTSC RNF213 GRIK4 TRANK1 UTRN	4.55e-06	198	148	7	0e918e9db9b884f5328d438e90efe065e27266ee
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GIMAP4 SAMD9 CTSC RNF213 GRIK4 TRANK1 UTRN	4.55e-06	198	148	7	ce92d5fbc2eac27fb246b044fb1914ab92506275
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	GIMAP4 SAMD9 CTSC RNF213 GRIK4 TRANK1 UTRN	4.55e-06	198	148	7	fed823d6e684d113bcc9ff3cd1803bb001aa02fa
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GIMAP4 SAMD9 CTSC RNF213 GRIK4 TRANK1 UTRN	4.55e-06	198	148	7	1ef3a6bd681c223eed58300348adfef89df5563c
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UBR2 RNF213 ANKRD36C CDC14A DDX6 RORA UTRN	4.70e-06	199	148	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	COVID-19_Severe-Lymphoid_T/NK-NK_activated\|COVID-19_Severe / Disease group, lineage and cell class	GIMAP4 SAMD9 CTSC RNF213 GRIK4 TRANK1 UTRN	4.70e-06	199	148	7	edf5f80b4c299e6bf462675f2cd3329d86c923d8
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	4.70e-06	199	148	7	534dcfe8b65ad92bb8d749d1c7036ad4807e09cd
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	SAMD9 RNF213 ANKRD36C DDX6 CCND2 TRANK1 RORA	4.70e-06	199	148	7	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 RNF213 ZBTB1 DDX6 TRANK1 RORA UTRN	4.86e-06	200	148	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CILP ACTA2 ACTC1 ACTG2 TMEM131L LMOD1 FILIP1L	4.86e-06	200	148	7	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CILP ACTA2 ACTC1 ACTG2 TMEM131L LMOD1 FILIP1L	4.86e-06	200	148	7	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	GIMAP4 SAMD9 RNF213 CDC14A LGALS3BP CCND2 TRANK1	4.86e-06	200	148	7	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated\|COVID-19_Severe / Disease, condition lineage and cell class	GIMAP4 SAMD9 CTSC RNF213 TRANK1 RORA UTRN	4.86e-06	200	148	7	6a77f9643646bafc1157bf1fc1e4c614860ee642
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	GIMAP4 SAMD9 CDC14A CCND2 TRANK1 RORA EPHA1	4.86e-06	200	148	7	deeed668b129e66156b5f6abe1a07a9bf842a14d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GIMAP4 PDE4B FAM178B KDM5D GTDC1 MAP3K5	1.20e-05	152	148	6	aa88084ba1851d879ece82baa516f6b46cbd2eb8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BEST1 ODAD1 ACTA2 ACTC1 ACTG2 LMOD1	1.20e-05	152	148	6	bd1f36b436d8ab7dd8420f595b97d851eab31a38
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BEST1 ODAD1 ACTA2 ACTC1 ACTG2 LMOD1	1.20e-05	152	148	6	ee329249a034a969a16b26a224aa04249d67382d
ToppCell	BAL-Control-cDC_12\|Control / Compartment, Disease Groups and Clusters	CACNA1A ABCF1 PLCXD1 FAM111B SULT1A3 ANO7	1.29e-05	154	148	6	0121d08cc527aed9b3e11ff62bb9012916f5c56b
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	ANKRD36C KDM5D CDC14A TMEM131L RORA UTRN	1.72e-05	162	148	6	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM178B ACTA2 ACTG2 NABP2 LMOD1 ATP1A2	1.78e-05	163	148	6	8f24cef152f5965727bbeee116bd26c75cbba82a
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ACTA1 ACTA2 ACTG2 ABCG4 LMOD1 ATP1A2	1.78e-05	163	148	6	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD36C CDC14A CCND2 TTC21B RORA PRKDC	2.04e-05	167	148	6	83969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A TSSK6 SPPL2B H3C1 TSSK3 STAG3	2.04e-05	167	148	6	b94e8ee8c3fcebedd8fcd719eadddc04c7513c50
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	ACTA2 ACTC1 ACTG2 TMEM132E LMOD1 FILIP1L	2.65e-05	175	148	6	fed9e4120c758fdcc23bb248d1801002b0e0d485
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 WWP1 CCND2 RORA UTRN ACOXL	2.83e-05	177	148	6	dba8b30a311051c22ca5f77697f5dbf9423c3ba0
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 RNF213 LGALS3BP TRANK1 ERAP2 TOP1	3.01e-05	179	148	6	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.20e-05	181	148	6	25915e2500430a902db37d79a749ce2990b69810
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SMARCAD1 KDM5D CDC14A CCND2 MTR UTRN	3.20e-05	181	148	6	986c036e656f24fe374807e2711cec9e3c83c892
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1A PDE8A ACTA2 DSCAML1 LMOD1 UTRN	3.30e-05	182	148	6	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VPS33A ACTA2 ACTC1 ACTG2 REV3L LMOD1	3.30e-05	182	148	6	dfde2d9950f445c6c936ac828f7210de87bb45ec
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 CCND2 LMOD1 ATP1A2 UTRN FILIP1L	3.30e-05	182	148	6	ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VPS33A ACTA2 ACTC1 ACTG2 REV3L LMOD1	3.30e-05	182	148	6	52274af3136d4fd4a495f5882618444661421f0f
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTG2 SLC6A15 LMOD1 DAAM1 FILIP1L	3.41e-05	183	148	6	4060d979948e1dd7507977629a7fbdfa4ca65bb6
ToppCell	Pericytes-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ACTA1 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2	3.41e-05	183	148	6	d04deef7cd4e1738227a6593b84874ce0168c773
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	ITCH RNF213 ZBTB1 PTP4A2 RORA UTRN	3.41e-05	183	148	6	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTC1 ACTG2 XIRP2 LMOD1 ATP1A2	3.41e-05	183	148	6	6f5dbac2748f50105f0f548d189c42ef14287019
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTA2 ACTG2 SLC6A15 LMOD1 DAAM1 FILIP1L	3.41e-05	183	148	6	0d44a978221cf3f733704bf11863502805fba733
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 CCND2 LMOD1 ATP1A2 UTRN FILIP1L	3.51e-05	184	148	6	94748f63947db79a6b4540e3090a63689fdd9452
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 CCND2 LMOD1 ATP1A2 UTRN FILIP1L	3.51e-05	184	148	6	819b277ecced7b415e363c7e7ddbc6f3b2d296de
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PDE8A CDC14A DSCAML1 MAP3K5 LMOD1 RORA	3.51e-05	184	148	6	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ACTA1 ACTC1 ITGAV XIRP2 RABGAP1L ATP1A2	3.51e-05	184	148	6	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTA2 ACTG2 ABCG4 LMOD1 ATP1A2 FILIP1L	3.51e-05	184	148	6	603faafb7b289a3c0242c84fc800c050c8a092ea
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTA2 ACTG2 ABCG4 LMOD1 ATP1A2 FILIP1L	3.51e-05	184	148	6	c350504bfe0ec31cd2fc2199de9b5fff151a8c5e
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TSSK6 ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2	3.51e-05	184	148	6	590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Treg\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GIMAP4 CTSC RNF213 RABGAP1L RORA ACOXL	3.62e-05	185	148	6	c1a44b7eed72a673923a7c44d06f891f18aa5aad
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	UBR2 RNF213 ANKRD36C LRIG2 TMEM131L PRKDC	3.73e-05	186	148	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.73e-05	186	148	6	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	TTC28 ACTA2 ACTG2 LMOD1 RORA ATP1A2	3.84e-05	187	148	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 CTSC RNF213 CCND2 RORA UTRN	3.84e-05	187	148	6	0bca79cea4886b66350c56c61859bd71e1e7a85c
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Kitl_(CA1_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CYP26A1 GUCY2C SERPINA9 CNGA3	3.88e-05	57	148	4	504d3ba4f7625307f0352e2a402e7c7062a3ea7f
ToppCell	normal_Lung-Fibroblasts-Smooth_muscle_cells\|normal_Lung / Location, Cell class and cell subclass	ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	3.96e-05	188	148	6	fd70fb89570f014d1299c60fe017dc09f24e57c6
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	ACTA2 ACTC1 ACTG2 TMEM131L LMOD1 ATP1A2	3.96e-05	188	148	6	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A ACTA2 ACTG2 LMOD1 ATP1A2 FILIP1L	4.08e-05	189	148	6	d69b7a01dd4d6ad043bb6210e9ab34b49578389c
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A ACTA2 ACTG2 LMOD1 ATP1A2 FILIP1L	4.08e-05	189	148	6	2b5f1b4f173a224342ea4f10b193ee33b7662699
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A ACTA2 ACTG2 LMOD1 ATP1A2 FILIP1L	4.08e-05	189	148	6	43e131458d8a4b120f7a5fb3d0c5650abded15f6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1B ACTA2 ACTG2 LMOD1 IGSF1 ATP1A2	4.08e-05	189	148	6	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	Substantia_nigra\|World / BrainAtlas - Mouse McCarroll V32	KRT84 MAB21L3 XIRP2 GUCY2C IGSF1	4.13e-05	115	148	5	18174b8d57d444fab1e9d2b13d22939c83c958e0
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTA2 ACTG2 CCND2 LMOD1 ATP1A2 FILIP1L	4.20e-05	190	148	6	1d8e169d2448a34180c415843bb49aa45ed540c5
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GIMAP4 PDE4B CCND2 TRANK1 ERAP2 RORA	4.20e-05	190	148	6	55df73c8b696967a925b1772631f6900eff0fa30
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE4B ANKRD36C CDC14A MAP3K5 RORA UTRN	4.20e-05	190	148	6	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACTA2 ACTC1 ACTG2 FREM2 LMOD1 FILIP1L	4.20e-05	190	148	6	e102622f05c7f3e1bd8b224ea159d57033793ee0
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	ACTA2 ACTC1 ACTG2 LMOD1 ATP1A2 FILIP1L	4.20e-05	190	148	6	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GIMAP4 PDE4B CCND2 TRANK1 ERAP2 RORA	4.20e-05	190	148	6	494fbab37305a7f92cddec75b291d42282555f5f
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	SAMD9 RNF213 IFNB1 TRANK1 ERAP2 RABGAP1L	4.32e-05	191	148	6	2da876d26f37a00dbdf1ee79d724306e8b20f304
Drug	dopamine-4-O-sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.75e-08	7	147	4	CID000123932
Drug	2-naphthylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.75e-08	7	147	4	CID000074428
Drug	2-iodo-4-azidophenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.75e-08	7	147	4	CID003035977
Drug	luciferyl sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.75e-08	7	147	4	CID011953812
Drug	AC1Q6OHG	CTSC SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.13e-07	19	147	5	CID000115063
Drug	dopamine 3-O-sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.14e-07	8	147	4	CID000122136
Drug	6-anilino-2-thiouracil	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.14e-07	8	147	4	CID003037707
Drug	2-iodophenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.14e-07	8	147	4	CID000010784
Drug	NSC312786	ACTA1 ACTA2 ACTC1 ACTG2 ACKR2	1.96e-07	21	147	5	CID000329495
Drug	penton	ITCH WWP1 WWP2 ITGAV LGALS3BP PTP4A2	2.83e-07	42	147	6	CID000006550
Drug	Lactobionic acid [96-82-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	CACNA1A PDE4B ITCH UBE4B GTDC1 LMAN1 ANKRA2 GLG1 UTRN SEC23A	6.66e-07	198	147	10	1309_DN
Drug	8-bromoguanosine 3',5'-cyclic monophosphate	CACNA1A CACNA1B ACTA1 ACTA2 ACTC1 ACTG2 LGALS3BP PTPN3 GUCY2C PRKAR2A CNGA3 TOP1	7.99e-07	308	147	12	CID000001915
Drug	blebbistatin	CACNA1A ACTA1 ACTA2 ACTC1 ACTG2 MYO5C CCND2 EPHA1	8.80e-07	116	147	8	CID003476986
Drug	CID5288653	ACTA1 ACTA2 ACTC1 ACTG2 MAP3K5	9.14e-07	28	147	5	CID005288653
Drug	guanosine 3',5'-cyclic monophosphoric acid	CACNA1A CACNA1B PDE4B PDE8A ACTA1 ACTA2 ACTC1 ACTG2 ABCC5 GRIN2D EZH1 LGALS3BP GUCY2C PRKAR2A ATP1A2 CNGA3	1.07e-06	577	147	16	CID000000295
Drug	EM-139	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.14e-06	13	147	4	CID000131427
Drug	3,3'-T2	SLC7A7 SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.31e-06	30	147	5	CID000065559
Drug	naphthalenemethanol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.59e-06	14	147	4	CID000020908
Drug	deoxoestrone	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.59e-06	14	147	4	CID000005888
Drug	arylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.15e-06	15	147	4	CID000074426
Drug	cyclobenzaprine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.15e-06	15	147	4	CID000002895
Drug	N,N'-p-phenylenedimaleimide	ACTA1 ACTA2 ACTC1 ACTG2 DLAT	2.51e-06	34	147	5	CID000076765
Drug	A-44	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.86e-06	16	147	4	CID000120353
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; HL60; HT_HG-U133A	SAMD9 PDE8A RRM1 PPP2R1B LMAN1 ANKRA2 CTH UTRN SEC23A	3.49e-06	186	147	9	1323_DN
Drug	benzilic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.72e-06	17	147	4	CID000006463
Drug	dopamine	CACNA1A CACNA1B ACTA1 ACTA2 ACTC1 ACTG2 SLC6A15 GRIK4 GRIN2D SULT1A2 PPP2R1B SULT1A4 H3C1 SULT1A1 SULT1A3 GUCY2C SNRPE	3.90e-06	715	147	17	CID000000681
Drug	1 C2	CACNA1A KDM5D SULT1A2 SULT1A4 SULT1A1 SULT1A3 TOP1	3.93e-06	100	147	7	CID005327152
Drug	foscarnet	CACNA1A CACNA1B ACTA1 ACTA2 ACTC1 ACTG2 REV3L RRM1 ITGAV	4.15e-06	190	147	9	CID000003414
Drug	K-Cl	CACNA1A CACNA1B ACTA1 ACTA2 ACTC1 ACTG2 GRIK4 REV3L INTS8 MYO5C GUCY2C MTR PRKAR2A ATP1A2 CHURC1	4.20e-06	567	147	15	CID000004873
Drug	Nsc687160	ACTA1 ACTA2 ACTC1 ACTG2	4.76e-06	18	147	4	CID005459290
Drug	Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; HL60; HT_HG-U133A	BEST1 FLT3 PDE4B ITCH WASHC4 PDE8A CDC14A GLG1 UTRN	4.92e-06	194	147	9	1274_UP
Drug	Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A	TTC28 ACTG2 GTDC1 ZBTB1 MAP3K5 PPP2R1B GLG1 SIPA1L1 UTRN	5.57e-06	197	147	9	3459_UP
Drug	Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A	CILP ACTG2 MAP3K5 LMAN1 PRKAR2A TMEM131L UTRN WDR62 EPHA1	5.81e-06	198	147	9	5870_UP
Drug	tolytoxin	ACTA1 ACTA2 ACTC1 ACTG2	6.00e-06	19	147	4	CID006440827
Drug	pedunculagin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.00e-06	19	147	4	CID000442688
Drug	m2-19	ACTA1 ACTA2 ACTC1 ACTG2	6.00e-06	19	147	4	CID000079129
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	WWP2 DDX6 MAP3K5 ERAP2 MCM3AP ETNK2 NABP2 UTRN STAG3	6.30e-06	200	147	9	7152_UP
Drug	Ro-1724	PDE4B PDE8A ACTA1 ACTA2 ACTC1 ACTG2 PRKAR2A	7.40e-06	110	147	7	CID000005087
Drug	PLP-Glu	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.46e-06	20	147	4	CID000444293
Drug	Phosphoadenosine Phosphosulfate	SULT1A2 SULT1A1 SULT1A3	9.06e-06	7	147	3	ctd:D010724
Drug	N-hydroxy-2-aminofluorene	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.17e-06	21	147	4	CID000005895
Drug	AC1L8NVR	ACTA1 ACTA2 ACTC1 ACTG2	9.17e-06	21	147	4	CID000384633
Drug	NDPS	RRM1 SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.04e-05	45	147	5	CID000090363
Drug	1IIg	REV3L SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.04e-05	45	147	5	CID000001682
Drug	MeA alpha C	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.11e-05	22	147	4	CID000062244
Drug	AABSSN	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.11e-05	22	147	4	CID005464134
Drug	taselin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.34e-05	23	147	4	CID000023846
Drug	N-hydroxy-4-aminobiphenyl	SULT1A2 SULT1A1 SULT1A3	1.44e-05	8	147	3	ctd:C014593
Drug	plakin	ACTA1 ACTA2 ACTC1 ACTG2 UTRN DYNC1H1	1.53e-05	82	147	6	CID000018752
Drug	AalphaC	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.60e-05	24	147	4	CID000062805
Drug	formamide	ACTA1 ACTA2 ACTC1 ACTG2 SMARCAD1 REV3L	1.88e-05	85	147	6	CID000000713
Drug	P2-N	CACNA1A SULT1A2 SULT1A1 MTR	1.90e-05	25	147	4	CID011987828
Drug	AzMC	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.90e-05	25	147	4	CID000064986
Drug	minoxidil sulphate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.90e-05	25	147	4	CID000004202
Drug	2-pentanone	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.90e-05	25	147	4	CID000007895
Drug	alpha-methyldopamine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.23e-05	26	147	4	CID000017005
Drug	glycolithocholic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.23e-05	26	147	4	CID000115245
Drug	1m2q	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.23e-05	26	147	4	CID005326637
Drug	Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; HL60; HT_HG-U133A	BEST1 PDE4B PDE8A ITGAV ZBTB1 CDC14A UTRN SEC23A	2.47e-05	182	147	8	1280_UP
Drug	thryroxine	ACTA1 ACTA2 ACTC1 ACTG2 KDM5D SULT1A2 SULT1A1 CTH ATP1A2 SERPINA9	2.79e-05	302	147	10	CID000000853
Drug	Glu-P-2	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.49e-05	29	147	4	CID000049970
Drug	manidipine	CACNA1A CACNA1B ACTA1 ACTA2 ACTC1 ACTG2	3.54e-05	95	147	6	CID000004008
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	PDE8A RRM1 MAP3K5 LMAN1 CTH PRKDC UTRN SEC23A	3.76e-05	193	147	8	4566_DN
Drug	Rp-cAMPS	ACTA1 ACTA2 ACTC1 ACTG2 GRIK4 GRIN2D GUCY2C PRKAR2A	3.90e-05	194	147	8	CID006426631
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	UBR2 SAMD9 SPPL2B EZH1 GTDC1 PPP2R1B NABP2 DAAM1	3.90e-05	194	147	8	1264_DN
Drug	acetaminophen glucuronide	ABCC5 SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.96e-05	59	147	5	CID000083944
Drug	azaspiracid	ACTA1 ACTA2 ACTC1 ACTG2	4.01e-05	30	147	4	CID006451158
Drug	Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	PDE8A UBE4B SPPL2B GTDC1 LMAN1 ERAP2 PRKAR2A UTRN	4.05e-05	195	147	8	2517_DN
Drug	Hydroxytryptophol	SULT1A1 SULT1A3	4.14e-05	2	147	2	ctd:D006917
Drug	5-hydroxymethylfurfural	SULT1A2 SULT1A1	4.14e-05	2	147	2	ctd:C008046
Drug	6-hydroxymelatonin	SULT1A1 SULT1A3	4.14e-05	2	147	2	ctd:C012365
Drug	DAPH; Down 200; 10uM; MCF7; HG-U133A	WASHC4 UBE4B REV3L LRIG2 PTP4A2 PTPN3 PPP2R1B GTF2H5	4.35e-05	197	147	8	624_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	ACTG2 EZH1 DDX6 PPP2R1B PRKAR2A ALK STAG3 FILIP1L	4.35e-05	197	147	8	3267_DN
Drug	A2'p5'A2'p5'A	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.58e-05	31	147	4	CID000122642
Drug	barium hydroxide	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.58e-05	31	147	4	CID000028387
Drug	acetaminophen sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.58e-05	31	147	4	CID000083939
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A	TTC28 VPS33A ZBTB1 CDC14A LMAN1 GLG1 ETNK2 WDR62	4.67e-05	199	147	8	2270_DN
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	UBR2 TTC28 CYP26A1 GTDC1 CDC14A PPP2R1B RABGAP1L PRKAR2A	4.84e-05	200	147	8	4818_DN
Drug	PI(3,4,5)P3	ACTA1 ACTA2 ACTC1 ACTG2 CDC14A PTPN3 ALK	5.07e-05	148	147	7	CID000643963
Drug	AC1L1HS4	ACTA1 ACTA2 ACTC1 ACTG2	5.21e-05	32	147	4	CID000004267
Drug	DCNP	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.90e-05	33	147	4	CID000012066
Drug	nitroglycerin	CACNA1A ACTA1 ACTA2 ACTC1 ACTG2 GUCY2C CTH ATP1A2	5.96e-05	206	147	8	CID000004510
Drug	N-acetyl-L-aspartate	CACNA1A IFNB1 EIF2B3 MTR DLAT ATP1A2	6.22e-05	105	147	6	CID000065065
Drug	DB07328	CACNA1A CACNA1B REV3L PTP4A2 SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.38e-05	208	147	8	CID011840913
Drug	nitric oxide	PDE4B GJB4 ACTA1 ACTA2 ACTC1 ACTG2 GRIN2D RRM1 SLC7A7 ITGAV MAP3K5 IFNB1 TYK2 GUCY2C MTR CTH PRKDC ATP1A2 UTRN	6.55e-05	1075	147	19	CID000145068
Drug	1,N6-ethenoadenosine 5'-diphosphate	ACTA1 ACTA2 ACTC1 ACTG2	6.65e-05	34	147	4	CID000001312
Drug	AC1NSKFN	ACTA1 ACTA2 ACTC1 ACTG2	8.37e-05	36	147	4	CID005311324
Drug	n-butyl acetate	SULT1A2 SULT1A1 SNRPE	9.11e-05	14	147	3	CID000031272
Drug	mefenamic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.33e-05	37	147	4	CID000004044
Drug	HU-211	ACTA1 ACTA2 ACTC1 ACTG2 GRIK4 GRIN2D	9.83e-05	114	147	6	CID000107778
Drug	phenylhydroxylamine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.04e-04	38	147	4	CID000007518
Drug	1tjp	ACTA1 ACTA2 ACTC1 ACTG2 GRIN2D ALK	1.08e-04	116	147	6	CID005459371
Drug	gallic acid	RRM1 SULT1A2 SULT1A4 SULT1A1 SULT1A3 TOP1	1.08e-04	116	147	6	CID000000370
Drug	ITdU	ACTA1 ACTA2 ACTC1 ACTG2 SULT1A2 SULT1A4 SULT1A1 SULT1A3 GUCY2C	1.22e-04	292	147	9	CID000000076
Drug	8-azaadenine	SULT1A1 SULT1A3	1.24e-04	3	147	2	ctd:C006654
Drug	3,3'-diiodothyronine	SULT1A1 SULT1A3	1.24e-04	3	147	2	ctd:C030629
Drug	5-hydroxy-3-methylindole	SULT1A2 SULT1A1	1.24e-04	3	147	2	CID000192734
Drug	5-hydroxyindole	SULT1A1 SULT1A3	1.24e-04	3	147	2	ctd:C026785
Drug	Minoxidil	SULT1A1 SULT1A3	1.24e-04	3	147	2	ctd:D008914
Drug	magnesium	PDE4B PDE8A CILP ACTA1 ACTA2 ACTC1 ACTG2 GRIK4 GRIN2D RRM1 MYO5C MRPL17 GUCY2C MTR PRKAR2A DLAT ATP1A2 ALK TOP1 DYNC1H1 SEC23A	1.24e-04	1325	147	21	CID000000888
Disease	Moyamoya disease (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	3.65e-08	8	143	4	DOID:13099 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	3.65e-08	8	143	4	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	3.65e-08	8	143	4	DOID:0081112 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	3.65e-08	8	143	4	DOID:14004 (implicated_via_orthology)
Disease	intestinal atresia (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-07	10	143	4	DOID:10486 (implicated_via_orthology)
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTA1 ACTA2 ACTC1 ACTG2	1.09e-07	10	143	4	DOID:13832 (implicated_via_orthology)
Disease	Moyamoya disease 1	ACTA2 RNF213	2.33e-05	2	143	2	C2931384
Disease	epilepsy and migraine	CACNA1A ATP1A2	2.33e-05	2	143	2	C0270816
Disease	Familial or sporadic hemiplegic migraine	CACNA1A ATP1A2	6.97e-05	3	143	2	cv:CN295307
Disease	Familial hemiplegic migraine	CACNA1A ATP1A2	6.97e-05	3	143	2	cv:C0338484
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1A CACNA1B	6.97e-05	3	143	2	DOID:0111181 (implicated_via_orthology)
Disease	total blood protein measurement	FLT3 CYP26A1 BCKDHA MAP3K5 CCND2 PTPN3 TMEM131L ANO7 RORA ACOXL	7.11e-05	449	143	10	EFO_0004536
Disease	Fetal Growth Retardation	SAMD9 ACTA2 CTH	1.20e-04	20	143	3	C0015934
Disease	Alternating hemiplegia of childhood	CACNA1A ATP1A2	1.39e-04	4	143	2	C0338488
Disease	migraine (implicated_via_orthology)	CACNA1A CACNA1B	1.39e-04	4	143	2	DOID:6364 (implicated_via_orthology)
Disease	Megacystis microcolon intestinal hypoperistalsis syndrome	ACTG2 LMOD1	1.39e-04	4	143	2	C1608393
Disease	epilepsy (implicated_via_orthology)	CACNA1A CACNA1B GRIN2D ETNK2 ATP1A2 DYNC1H1	1.48e-04	163	143	6	DOID:1826 (implicated_via_orthology)
Disease	megacystis-microcolon-intestinal hypoperistalsis syndrome (is_implicated_in)	ACTG2 LMOD1	2.31e-04	5	143	2	DOID:0060610 (is_implicated_in)
Disease	Moyamoya disease (is_implicated_in)	ACTA2 RNF213	2.31e-04	5	143	2	DOID:13099 (is_implicated_in)
Disease	age at first birth measurement	CACNA1A PDE4B SLC6A15 SIPA1L1 IGSF1	3.04e-04	120	143	5	EFO_0009101
Disease	Microcephaly	PUS3 ATP1A2 DYNC1H1 WDR62	3.20e-04	67	143	4	C0025958
Disease	migraine with aura (is_implicated_in)	CACNA1A ATP1A2	3.45e-04	6	143	2	DOID:10024 (is_implicated_in)
Disease	Intellectual Disability	CACNA1B PUS3 GRIN2D H3-4 DDX6 RABL6 RORA DYNC1H1 WDR62	3.46e-04	447	143	9	C3714756
Disease	lysophosphatidylethanolamine 20:4 measurement	BEST1 LRIG2 SEC23A	3.71e-04	29	143	3	EFO_0010370
Disease	familial hemiplegic migraine (implicated_via_orthology)	CACNA1A ATP1A2	4.82e-04	7	143	2	DOID:0060178 (implicated_via_orthology)
Disease	Urogenital Abnormalities	SAMD9 DDX6	4.82e-04	7	143	2	C0042063
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1A CACNA1B	4.82e-04	7	143	2	DOID:0050951 (implicated_via_orthology)
Disease	Heart Failure, Diastolic	PTP4A2 PTPN3 SIPA1L1	5.47e-04	33	143	3	C1135196
Disease	Colonic Neoplasms	CYP26A1 ACTA2 ACTG2 CCND2 SULT1A1	8.91e-04	152	143	5	C0009375
Disease	monocyte percentage of leukocytes	UBR2 FLT3 CYP26A1 ABCC5 DDX6 ABCG4 GLG1 MCM3AP ACKR2 PRKDC ACOXL	9.00e-04	731	143	11	EFO_0007989
Disease	Malignant tumor of colon	CYP26A1 ACTA2 ACTG2 CCND2 SULT1A1	1.09e-03	159	143	5	C0007102
Disease	Disease Exacerbation	ABCF1 CTSC CNPY2 RRM1 TOP1	1.28e-03	165	143	5	C0235874
Disease	X-12707 measurement	SULT1A2 SULT1A1	1.49e-03	12	143	2	EFO_0800720
Disease	Myocardial Ischemia	PDE4B CTSC CCND2 SULT1A1 DLAT	1.71e-03	176	143	5	C0151744
Disease	lymphocyte count	GIMAP4 FLT3 TTC28 UBE4B WWP2 ABCC5 HIF3A RRM1 ZBTB1 CCND2 TYK2 ABCG4 DDX18 MCM3AP NLRC3 ACOXL	2.01e-03	1464	143	16	EFO_0004587
Disease	granulocyte percentage of myeloid white cells	UBR2 FLT3 GLG1 ACKR2 PRKDC ACOXL	2.01e-03	268	143	6	EFO_0007997
Disease	Malformations of Cortical Development	DYNC1H1 WDR62	2.04e-03	14	143	2	C1955869
Disease	ascorbic acid 3-sulfate measurement	SULT1A2 SULT1A1	2.04e-03	14	143	2	EFO_0800173
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	EIF2B3 MTR	2.04e-03	14	143	2	C1858991
Disease	Cortical Dysplasia	DYNC1H1 WDR62	2.04e-03	14	143	2	C0431380
Disease	Malignant neoplasm of breast	ACTA2 GRIN2D SLC7A7 IFNB1 SULT1A1 FAM83F N4BP2 SIPA1L1 DDX18 NUP133 MTR ALK TOP1	2.24e-03	1074	143	13	C0006142
Disease	Bipolar Disorder	CACNA1A CACNA1B PDE4B GRIK4 TRANK1 MTR RORA ATP1A2	2.34e-03	477	143	8	C0005586
Disease	Chromosome Aberrations	SULT1A2 SULT1A1	2.68e-03	16	143	2	C0008625
Disease	Keratoderma, Palmoplantar	CTSC SMARCAD1	2.68e-03	16	143	2	C4551675
Disease	Autosome Abnormalities	SULT1A2 SULT1A1	2.68e-03	16	143	2	C0004403
Disease	neutrophil percentage of leukocytes	UBR2 FLT3 ZBTB1 TYK2 ABCG4 ERAP2 GLG1 PRKDC ACOXL	3.00e-03	610	143	9	EFO_0007990
Disease	Moyamoya Disease	ACTA2 RNF213	3.02e-03	17	143	2	C0026654
Disease	C-X-C motif chemokine 16 measurement	ACKR2 ACOXL	3.39e-03	18	143	2	EFO_0010911
Disease	brain infarction	EIF2B3 ALK	3.39e-03	18	143	2	EFO_0004277
Disease	Global developmental delay	CACNA1B PUS3 SZT2 DDX6	4.07e-03	133	143	4	C0557874
Disease	COVID-19, osteoarthritis	TYK2 ACKR2	4.18e-03	20	143	2	MONDO_0005178, MONDO_0100096
Disease	Arthrogryposis	ATP1A2 DYNC1H1	4.61e-03	21	143	2	C0003886
Disease	smoking behaviour measurement	PDE4B SLC6A15 REV3L H3C1 GTF2H5	4.62e-03	222	143	5	EFO_0005671
Disease	Profound Mental Retardation	H3-4 RABL6 DYNC1H1 WDR62	4.75e-03	139	143	4	C0020796
Disease	Mental Retardation, Psychosocial	H3-4 RABL6 DYNC1H1 WDR62	4.75e-03	139	143	4	C0025363
Disease	Mental deficiency	H3-4 RABL6 DYNC1H1 WDR62	4.75e-03	139	143	4	C0917816

Protein segments in the cluster

Peptide	Gene	Start	Entry
MQALYYVCREGDIEK	TTC21B	251	Q7Z4L5
GIFFISCMSLDKYLE	ACKR2	131	O00590
LGVEFFDEKLNSLCM	PPP2R1B	446	P30154
ECVLKVMAFGILNYF	CACNA1A	1611	O00555
LGCKETFNLLYMESD	EPHA1	116	P21709
NEFEDYCLKRELLMG	DDX6	96	P26196
FKNLDFGIDMDSRIC	ABCF1	641	Q8NE71
EMFDKLYILSQGQCI	ABCG4	266	Q9H172
EKLCYVALDFENEMA	ACTA1	216	P68133
GELIGACEFMKDRLY	CDC14A	6	Q9UNH5
EKLCYVALDFENEMA	ACTA2	216	P62736
LKAGDQIICMDDVYG	CTH	101	P32929
KLCYVALDFENEMAT	ACTG2	216	P63267
EEQQLMFEKLTLYCD	BEST1	56	O76090
VKMLLDCGVDVNEYD	ANKRA2	231	Q9H9E1
MECVLKIIAFGVLNY	CACNA1B	1516	Q00975
DQEDQTLLMKFCLLY	ACOXL	501	Q9NUZ1
AEFLDVYKNCNGVVM	RABL6	131	Q3YEC7
VKLDTMIFGVIEYCE	GUCY2C	551	P25092
VCLGLEDLQYVFMIS	INTS8	446	Q75QN2
YFLQLKMDICEGRLT	PTPN3	126	P26045
KCEEEVFPLAMNYLD	CCND2	71	P30279
MIEKLLSYGANIEEC	ANKRD36C	146	Q5JPF3
CEGLFDEYLEMVLQF	ANO7	701	Q6IWH7
SLAEKYCDFDILVQM	NUP133	861	Q8WUM0
EELDLVYDVKDCGMN	TCTE1	241	Q5JU00
DLFMLGYFQLLECDL	ESPNL	856	Q6ZVH7
LKDIGFDECLVQMFF	OR52N4	91	Q8NGI2
CEYQELMNAKLGLDI	KRT84	446	Q9NSB2
IAYENKALMLCEGLF	LGALS3BP	516	Q08380
YEQDMKAFGVDLALL	NLRC3	416	Q7RTR2
KRLEYQMCLAKEAGA	LRSAM1	16	Q6UWE0
DIDDMKICYVLREGA	FREM2	1726	Q5SZK8
LKEMYQDLRNKGVFC	MCM3AP	786	O60318
MEKALGLYQCDTELL	KDM5D	1106	Q9BY66
AILDYILAKLCGVDM	FSIP2	1486	Q5CZC0
GITNKLVACYVEEDM	ETNK2	91	Q9NVF9
GVYNREAMLNFCEKE	LMOD1	61	P29536
GFESLEECYMAKILV	DLAT	136	P10515
CQGLMEKFQFELTLD	PDE4B	671	Q07343
MACYNELLQLEFGEV	PDE8A	191	O60658
ALDMYKLAGAVLFCI	NRSN1	111	Q8IZ57
DYEFCAKVENMIIPA	LMAN1	226	P49257
CKRQLATGDEFYLME	LHX3	121	Q9UBR4
MALQEACESYLVGLF	H3-4	91	Q16695
MALQEACEAYLVGLF	H3C1	91	P68431
GFMYKNLQCLVIDEA	DDX18	321	Q9NVP1
CYEDALNKLSQLMGE	ODAD1	266	Q96M63
YLVACIKNIFGDMLC	PLCXD1	166	Q9NUJ7
MKYLTVGDLEDCLLN	MAB21L3	1	Q8N8X9
EDSVLFNKLTYLGCM	RABGAP1L	126	Q5R372
QYFDAKELEVLLCGM	ITCH	771	Q96J02
YLVDCDEVIFMKEGC	ABCC5	746	O15440
EDLLCFAYQVAKGME	FLT3	786	P36888
DGLSCILNFLKTMDY	DAAM1	156	Q9Y4D1
CLKKYIVDFLMENGS	EIF2B3	206	Q9NR50
YRLICGFMDDCKNDI	GLG1	231	Q92896
AILCFLAYGIQAAME	ATP1A2	106	P50993
LQDLVFMLFKEGYAE	IGSF1	156	Q8N6C5
KAICGLIDDYSMVRF	GPN3	216	Q9UHW5
EKMDLALLEAQYGFV	FILIP1L	96	Q4L180
KGMDEGEYLCSVLIQ	DSCAML1	566	Q8TD84
GLMQCEELIAYLRDE	ITGAV	561	P06756
LLEEICDRMKEYGEQ	CNPY2	81	Q9Y2B0
YCLKDRMNFDIPEEI	IFNB1	51	P01574
NLSEVFYLVGKRCME	GJB4	201	Q9NTQ9
FYGGCNEALMKLELV	CTSC	351	P53634
DEVSYNKGACILNML	ERAP2	451	Q6P179
LFCDEINLPDMDKYG	DYNC1H1	2661	Q14204
AYAVGDVKCLVMDVQ	PRKAR2A	351	P13861
DMEILEQLKYIGCVI	CYP26A1	346	O43174
IEFGYSMDSILCDIK	FAM111B	681	Q6SJ93
NDRYEGFCVDMLKEL	GRIK4	441	Q16099
KDDYFQVLCMADVVI	GTDC1	351	Q4AE62
GQFEIEKSCELLFQM	DHX40	281	Q8IX18
SLAYCMKLEEQVEFL	KIF28P	646	B7ZC32
LELFMAQCYGNISDL	BCKDHA	171	P12694
CLVGRIYKDMFLDSN	MAP3K5	391	Q99683
IYEQLCLFEDKVATM	SZT2	186	Q5T011
DYLVEINKILLCMDD	UTRN	1871	P46939
GCVIERAFKDEYMVN	MRPL39	151	Q9NYK5
NIAVCFVYGIDKFME	SLC6A15	541	Q9H2J7
MAVEFPLVLYDCKFE	PUS3	316	Q9BZE2
CAMSEKQEQLYLGLF	SMARCAD1	741	Q9H4L7
KGCYLESDDVLRLQM	TMEM131L	246	A2VDJ0
DLEIGMYALLGVFCL	TMEM132E	886	Q6IEE7
QDLMDIFGDRYCALN	GIMAP4	176	Q9NUV9
QCVGLAVDMDEIEKY	NBPF19	1371	A0A087WUL8
CVGLAVDMDEIEKYQ	NBPF19	1616	A0A087WUL8
QCVGLAVDMDEIEKY	NBPF19	2591	A0A087WUL8
CVGLAVDMDEIEKYQ	NBPF19	2836	A0A087WUL8
LIETFCAFYQDLKGM	SAMD9	556	Q5K651
AYTDENLMGLIELLC	FAM178B	441	Q8IXR5
DACYLKALEGFVMVL	HIF3A	86	Q9Y2N7
FAKLIMAGNYEEALC	MTR	386	Q99707
MAGNYEEALCVAKVQ	MTR	391	Q99707
KEKLCYVALDFEQEM	POTEJ	876	P0CG39
EDYNKAMELDCLLGI	SIPA1L1	866	O43166
KFYDLFLMECEESPN	RHOBTB1	291	O94844
FEEAFICLQKLMAAV	SWT1	791	Q5T5J6
LDEAGVKYFLEMCQD	FAM83F	196	Q8NEG4
VKYFLEMCQDLQLTD	FAM83F	201	Q8NEG4
QILDMIYQGGDLEKC	SULT1A4	56	P0DMN0
QILDMIYQGGDLEKC	SULT1A3	56	P0DMM9
DIYACALDQTGLLEM	SEC23A	346	Q15436
DTELNCFVLQMDYKG	SERPINA9	251	Q86WD7
GIFNLEKDDMLYILV	ALK	761	Q9UM73
EKLCYVALDFENEMA	ACTC1	216	P68032
LEFKCSGMLYDQDRV	CILP	1006	O75339
FQEYTMLCLLCGKAE	CHURC1	81	Q8WUH1
IGYSDLFCLSKDDLM	CNGA3	571	Q16281
EDEKGDINMTIYCLL	XIRP2	1506	A4UGR9
DKTELYMLFINCLED	RNF213	4166	Q63HN8
YMLFINCLEDSILEK	RNF213	4171	Q63HN8
QLVMKGLLYECCVEF	WDR47	196	O94967
ECDPAMKQFLLYLDE	GTF2H5	11	Q6ZYL4
CGLELYFIQDMEILG	WWP2	666	O00308
ICELLQSGAIMNKFY	REV3L	136	O60673
GFCKLLLYGVLEMDA	STAG3	876	Q9UJ98
RIQKLCYGLNMDFVD	RRM1	21	P23921
EFAKRIDGFMELCQN	RORA	336	P35398
LVALALIECGMKYED	PTP4A2	111	Q12974
LIECGMKYEDAVQFI	PTP4A2	116	Q12974
IQVYEMLESADGKIC	TSSK3	71	Q96PN8
QILDMIYQGGDLEKC	SULT1A1	56	P50225
QILDMIYQGGDLEKC	SULT1A2	56	P50226
FEVMECIKGDQYIVD	WDR70	261	Q9NW82
MLNYLIECFDRVGIE	UBE4B	426	O95155
GIMALIYLCVEDIFQ	SLC7A7	366	Q9UM01
DLQKIGEFCMVYSEV	NABP2	91	Q9BQ15
FLLLAAQVACEYGMV	SPPL2B	16	Q8TCT7
DCFLLLEGAKEYAML	EZH1	336	Q92800
CIIGFDEYMNLVLDD	SNRPE	46	P62304
IKLCYDAFTENMAGE	PRKDC	1916	P78527
SAECFDLILQFMYLG	ZBTB1	71	Q9Y2K1
ILDAQDLDCYFTPMK	WDR62	876	O43379
EYTKKIENLCAMGFD	UBE2K	161	P61086
TMAFKCYEEQLDLGQ	TTC28	811	Q96AY4
LLDCYDKEIMEILNE	WASHC4	656	Q2M389
FEFIEVCNGKLYIVM	TSSK6	76	Q9BXA6
LLSMESEGAFKECYL	VPS33A	151	Q96AX1
YFDEKELEVMLCGMQ	WWP1	791	Q9H0M0
EFDLALKMYCQEELF	TRANK1	1821	O15050
LKMYCQEELFEEAAI	TRANK1	1826	O15050
YEVDLNKCGPMVLDA	SDHB	61	P21912
LEGFDAFLELLKCMQ	UBR2	501	Q8IWV8
QLGEMIQAYEKLCVE	TBKBP1	126	A7MCY6
NEKLLKEYGFCIMDN	TOP1	331	P11387
YDDCAKILGNTIMRE	PPIP5K1	346	Q6PFW1
DRAKMAVIEYKGNCL	MRPL17	116	Q9NRX2
CEDQGEKSLQLVMEY	TYK2	966	P29597
FIANVKIEDMGIYSC	LRIG2	661	O94898
LMALDQYQLEEFKLC	NLRP13	21	Q86W25
FLNCLKQYSGEEEFM	MYO5C	1451	Q9NQX4
VYLMLSECDFKVENA	N4BP2	66	Q86UW6
AVLNYMARKDEGCKL	GRIN2D	761	O15399